Descriptive data for PTLD rate and rituximab dosing. (A) PTLD rates between the posttransplant rituximab group and nonrituximab groups. (B) Indications for posttransplant rituximab. (C) Dosing details by indication. (D) Timing of rituximab dosing.
Figure 2.

Descriptive data for PTLD rate and rituximab dosing. (A) PTLD rates between the posttransplant rituximab group and nonrituximab groups. (B) Indications for posttransplant rituximab. (C) Dosing details by indication. (D) Timing of rituximab dosing.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal